Travere Therapeutics, Inc. · NASDAQ:TVTX
Armistice Capital, LLC reported a 7.52% stake in Travere Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Armistice Capital, LLC reported a 7.52% stake in Travere Therapeutics, Inc., 6,724,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 7.52%
- Shares
- 6,724,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 7.52% | 6,724,000 |
| Steven Boyd | 7.52% | 6,724,000 |
Source
Related
- Travere Therapeutics, Inc.
- Armistice Capital, LLC
- Travere Therapeutics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026